Marketing-authorisation holder
Synthaverse S.A.
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BCG Synthaverse 100 mg, poeder voor suspensie voor intravesicaal gebruikPoeder voor blaasspoeling | Bcg vaccine | Netherlands | Authorised | 2026 |
| Verocyt Synthaverse 100 mg, poeder voor suspensie voor intravesicaal gebruikPoeder voor blaasspoeling | Bcg vaccine | Netherlands | Authorised | 2026 |
| Vesiper Synthaverse 100 mg, poeder voor suspensie voor intravesicaal gebruikPoeder voor blaasspoeling | Bcg vaccine | Netherlands | Authorised | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- ImmunostimulantsAntineoplastic and immunomodulating agents · ATC L03A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- synthaverse
- synthaverse s a
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder